Article info

Original research
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

Authors

  1. Correspondence to Dr Timo K van den Berg; Timo.vandenBerg{at}byondis.com
View Full Text

Citation

van Helden MJ, Zwarthoff SA, Arends RJ, et al
BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells

Publication history

  • Accepted March 26, 2023
  • First published April 17, 2023.
Online issue publication 
December 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.